Verenium Corporation

Last updated
Verenium Corporation
TypePublic Company (Nasdaq:  VRNM) [1]
IndustryIndustrial Biotechnology
Founded2007
Headquarters San Diego, California
Key people
James Levine (President & CEO), Janet Roemer (COO), Jeff Black (CFO)
Products Enzymes
Number of employees
130
Website www.verenium.com

Verenium Corporation was a San Diego, California-based industrial biotechnology company founded in 2007 as the result of a merger between Diversa (San Diego) and Celunol (Cambridge, MA). [2] [3] The company specialized in research and development for the production of high performance enzymes used in industrial applications, including biofuel generation, hydraulic fracturing. [3] [4] Verenium was acquired by BASF corporation in 2013. [3] The company's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries including the global food and fuel markets.

Contents

Using proprietary and patented genomic technologies, BASF extracts microbial DNA directly from collected samples to avoid the slow and often impossible task of growing microbes in the laboratory. [5] BASF then mines its collection of microbial genes, numbering in the billions, using high-throughput screening technologies designed to identify unique enzymes as product candidates. [5] As required, these enzymes can then be further optimized for commercial use through the company's patented DirectEvolution technologies. By combining discovery and laboratory evolution technologies, Verenium successfully developed and commercialized a suite of highly differentiated enzyme products tailored to meet the specific needs of companies in various markets, including grain processing, biofuels, animal health and nutrition and other industries. [6] These enzymes products are now offered by BASF.

On September 20, 2013, Verenium entered an agreement to be acquired by BASF, with a 71% acquisition of Verenium. [1] [7]

See also

Related Research Articles

The Monsanto Company was an American agrochemical and agricultural biotechnology corporation founded in 1901 and headquartered in Creve Coeur, Missouri. Monsanto's best known product is Roundup, a glyphosate-based herbicide, developed in the 1970s. Later, the company became a major producer of genetically engineered crops. In 2018, the company ranked 199th on the Fortune 500 of the largest United States corporations by revenue.

<span class="mw-page-title-main">Exoenzyme</span> Exoenzyme

An exoenzyme, or extracellular enzyme, is an enzyme that is secreted by a cell and functions outside that cell. Exoenzymes are produced by both prokaryotic and eukaryotic cells and have been shown to be a crucial component of many biological processes. Most often these enzymes are involved in the breakdown of larger macromolecules. The breakdown of these larger macromolecules is critical for allowing their constituents to pass through the cell membrane and enter into the cell. For humans and other complex organisms, this process is best characterized by the digestive system which breaks down solid food via exoenzymes. The small molecules, generated by the exoenzyme activity, enter into cells and are utilized for various cellular functions. Bacteria and fungi also produce exoenzymes to digest nutrients in their environment, and these organisms can be used to conduct laboratory assays to identify the presence and function of such exoenzymes. Some pathogenic species also use exoenzymes as virulence factors to assist in the spread of these disease-causing microorganisms. In addition to the integral roles in biological systems, different classes of microbial exoenzymes have been used by humans since pre-historic times for such diverse purposes as food production, biofuels, textile production and in the paper industry. Another important role that microbial exoenzymes serve is in the natural ecology and bioremediation of terrestrial and marine environments.

Danisco A/S is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar, and Dansk Handels- og Industri Company.

Cellulosic ethanol is ethanol produced from cellulose rather than from the plant's seeds or fruit. It can be produced from grasses, wood, algae, or other plants. It is generally discussed for use as a biofuel. The carbon dioxide that plants absorb as they grow offsets some of the carbon dioxide emitted when ethanol made from them is burned, so cellulosic ethanol fuel has the potential to have a lower carbon footprint than fossil fuels.

Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.

<span class="mw-page-title-main">Genzyme</span> Company

Genzyme was an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America's leading innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi.

This page provides an alphabetical list of articles and other pages about biotechnology.

<span class="mw-page-title-main">Jay Keasling</span> American biologist

Jay D. Keasling is a professor of chemical engineering and bioengineering at the University of California, Berkeley. He is also associate laboratory director for biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute. He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering.

The Energy Biosciences Institute (EBI) is an organization dedicated to developing new sources of energy and reducing the impact of energy consumption. It was created in 2007 to apply advanced knowledge of biology to the challenges of responsible, sustainable energy production and use. Its main goal is to develop next-generation biofuels—that is, biofuels that are made from the non-edible parts of plants and reduce greenhouse gas emissions.

Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies. The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA.

<span class="mw-page-title-main">Sid Martin Biotechnology Incubator</span> Business incubator n the United States

UF Innovate | Accelerate @ Sid Martin Biotech is located in Alachua, Florida, in Progress Park. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the university. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.

<span class="mw-page-title-main">National Institute of Molecular Biology and Biotechnology</span>

LS-9 Inc was a venture-funded company focused on producing diesel fuel from transgenic organisms. It launched in 2005, took in $81 million in investment, and in 2013 was sold to Renewable Energy Group for $40 million in cash and stock, and an additional $21.5 million if technology and production milestones were met.

<span class="mw-page-title-main">Idemitsu Kosan</span> Japanese petroleum company

The Idemitsu Kosan Company, Ltd. is a Japanese petroleum company. It owns and operates oil platforms, refineries, produces and sells petroleum, oils and petrochemical products, and also operates gas stations under the apollostation brand and in its own Idemitsu and Shell brands, the latter under license from Royal Dutch Shell.

<span class="mw-page-title-main">Joule Unlimited</span>

Joule Unlimited, formerly known as Joule Biotechnologies, was a producer of alternative energy technologies based in Bedford, Massachusetts. The company developed a process to generate hydrocarbon-based fuel by combining non-fresh water, nutrients, cyanobacteria, carbon dioxide, and sunlight. After ten years of operation and building a demonstration plant in New Mexico, the company shut down in August 2017. The company shut down after management was unable to raise money.

Willem P. C. "Pim" Stemmer was a Dutch scientist and entrepreneur who invented numerous biotechnologies. He was the founder and CEO of Amunix Inc., a company that creates "pharmaceutical proteins with extended dosing frequency". His other prominent inventions include DNA shuffling, now referred to as molecular breeding. He holds more than 97 patents. Stemmer was honored with the Charles Stark Draper Prize in 2011 for the pioneering contributions to directed evolution which won the Nobel Prize in Chemistry in 2018. He was elected as member of National Academy of Engineering.

BioTork is a biotechnology company founded in 2008 that specializes in the optimization of industrial fermentation processes. BioTork provides robust microorganisms that are able to convert low-value, raw carbon sources such as agroindustrial by-products and waste into high-value chemical commodities. These biochemical commodities such as omega-3 oil, lipids, fuels, enzymes, plastics and other compounds are derived from renewable feedstock using a continuous culture technology.

Banwari Lal is an Indian environmental and industrial biotechnologist and the director of the Environmental and Industrial Biotechnology Division at The Energy and Resources Institute (TERI). Known for the development of oilzapper technology, Dr. Lal is the chief executive officer of ONGC-TERI Biotech Limited, a collaborative venture between TERI and the Oil and Natural Gas Corporation since 2008. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2004. He have many Indian and international joint patents with ONGC, DBT, IOCL, OIL INDIA and TERI.

N. Louise Glass is the Fred E. Dickinson Chair of Wood Science and Technology at the University of California, Berkeley. She specialises in plant and microbial biology, particularly fungal cell biology and genetics

References

  1. 1 2 Logan, Rob (December 8, 2017). "Verenium (VRNM) vs. Trecora Resources (NYSE:TREC) Critical Analysis". The Ledger Gazette. Retrieved December 10, 2017.
  2. "Diversa and Celunol Complete Merger to Create Verenium Corporation". Biospace. June 20, 2007.
  3. 1 2 3 Bigelow, Bruce V. (24 Sep 2013). "Aiming for Chartbuster, Germany's BASF Acquires San Diego's Verenium". Xconomy . San Diego, California, USA. Retrieved 9 Apr 2018.
  4. Runge, W. (2014). Technology Entrepreneurship : A Treatise on Entrepreneurs and Entrepreneurship for and in Technology Ventures. Vol 1 und Vol 2.:. KIT Scientific Publishing. p. 968. ISBN   978-3-7315-0107-7 . Retrieved December 10, 2017.
  5. 1 2 Arico, S. (2015). Ocean Sustainability in the 21st Century. Cambridge University Press. p. 207. ISBN   978-1-316-30077-0 . Retrieved December 10, 2017.
  6. Petroleum Review. Institute of Petroleum. 2008. p. 293. Retrieved December 10, 2017.
  7. "BASF announces cash offer to acquire specialized enzyme biotechnology company Verenium". BASF. 20 September 2013. Retrieved 21 September 2013.